Immucell (ICCC) Total Current Liabilities (2010 - 2026)
Immucell (ICCC) recorded Total Current Liabilities of $4.44 million in Q2 2026, down 0.2% from $4.45 million a year earlier.
Powered by 
Analysis
Immucell (ICCC) Total Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Immucell reported Total Current Liabilities of $3.98 million, down 9.8% from FY2024.
- Annual Total Current Liabilities has a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
- Across earlier years, Total Current Liabilities came in at $4.41 million in FY2024 (+5.1%), $4.2 million in FY2023 (+36.6%), $3.07 million in FY2022 (+21.2%) and $2.53 million in FY2021 (+14.6%).
- Quarterly Total Current Liabilities has ranged from $2.17 million in Q3 2021 to $4.56 million in Q2 2024 over the past five years.
- On a year-over-year basis, Total Current Liabilities rose in two of the last seven quarters, with growth averaging 1.2%.
- Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 53.5% in Q2 2023, against a decline of 10.5% in Q3 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 618.58 Bn | 537.11 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 507.51 Bn | 480.62 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 364.48 Bn | 318.85 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 297.05 Bn | 261.04 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.61 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 235.60 Bn | 191.00 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 191.42 Bn | 165.62 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 170.40 Bn | 117.05 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Immucell | 95.91 Mn | 73.36 Mn | 2.44 Mn | 4.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.44 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 4.45 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 4.41 Mn |
| Sep 30, 2024 | 4.47 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 4.18 Mn |
| Dec 31, 2023 | 4.20 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 4.19 Mn |
| Mar 31, 2023 | 3.84 Mn |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 2.71 Mn |
| Jun 30, 2022 | 2.73 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 2.53 Mn |
| Sep 30, 2021 | 2.17 Mn |
| Jun 30, 2021 | 2.03 Mn |
API Access
Immucell Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();